About Us

SynCardia Systems, LLC is a medical technology company focused on developing,manufacturing and marketing the SynCardia Total Artificial Heart, an implantable system designed to assume the full function of a failed human heart in patients suffering from end-stage bi-ventricular heart failure. The SynCardia TAH-t, in commercial use since 2004, is the world's only total artificial heart
that is commercially available and approved in the United States (FDA), European Union (CE Marked) and Canada (Health Canada) for use as a bridge to donor heart transplantation.